Evdokia Anagnostou is a child neurologist and senior scientist at Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. She is also professor of pediatrics at the University of Toronto.
Evdokia Anagnostou
Senior scientist
Holland Bloorview Kids Rehabilitation Hospital
From this contributor
Social perception problems cut across disorders
The ability to recognize emotions varies along a continuum that spans autism, attention deficit hyperactivity disorder and obsessive-compulsive disorder.
Social perception problems cut across disorders
By
Danielle Baribeau, Evdokia Anagnostou
29 September 2015 | 5 min read
Frontline diagnosis of autism
Targeted training opportunities and comprehensive guidelines can help community physicians diagnose many cases of autism, say Evdokia Anagnostou and Jessica Brian.
Frontline diagnosis of autism
By
Evdokia Anagnostou, Jessica Brian
11 March 2014 | 3 min read
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read